Accutar Biotechnology Receives NMPA Clearance of IND Application for AC0682 in ER-Positive Breast Cancer
BROOKLYN, N.Y. & SHANGHAI--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces...

Google extends voluntary buyouts to five more countries as AI costs pinch Alphabet
Douvikas hat-trick fuels Como’s record 9-1 demolition of Lens
Guirassy injured as Dortmund host Betis in Champions League
Valverde’s late winner has made his absence the real Real Madrid risk
Oil’s 12% crash is a Washington story, not a supply story 















